These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9742990)
21. New options in the prevention and treatment of breast carcinoma. Galleshaw J J Med Assoc Ga; 2003; 92(1):19-22. PubMed ID: 12743901 [No Abstract] [Full Text] [Related]
22. Chemoprevention: drug pricing and mortality: the case of tamoxifen. Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680 [TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of breast cancer. Dalton RR; Kallab AM South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947 [TBL] [Abstract][Full Text] [Related]
24. Breast Cancer Prevention Trial shows major benefit, some risk. Jpn J Clin Oncol; 1998 Jun; 28(6):417-8. PubMed ID: 9730162 [No Abstract] [Full Text] [Related]
25. Hormonal strategies for the prevention of breast cancer. Olsen MR; Love RR Cancer Treat Res; 1998; 94():135-57. PubMed ID: 9587686 [No Abstract] [Full Text] [Related]
26. A review of breast cancer chemoprevention. Chang JC Biomed Pharmacother; 1998; 52(3):133-6. PubMed ID: 9755806 [TBL] [Abstract][Full Text] [Related]
27. [To anticipate is also to be a bit biased]. Bellati C; Berrino F Epidemiol Prev; 1998; 22(4):193-4. PubMed ID: 10052255 [No Abstract] [Full Text] [Related]
28. [New developments in the hormonal treatment of breast cancer in postmenopausal women]. Trunet P; Marty M Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232 [TBL] [Abstract][Full Text] [Related]
29. Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Cuzick J; Forbes JF; Howell A J Natl Cancer Inst; 2006 May; 98(9):643; author reply 643-4. PubMed ID: 16670391 [No Abstract] [Full Text] [Related]
31. NCI study: more than 2 million U.S. women could benefit from tamoxifen. FDA Consum; 2003; 37(3):7. PubMed ID: 12793384 [No Abstract] [Full Text] [Related]
33. Drop-outs in tamoxifen prevention trials. Veronesi U; Maisonneuve P; Costa A; Rotmensz N; Boyle P Lancet; 1999 Jan; 353(9148):244. PubMed ID: 9923912 [No Abstract] [Full Text] [Related]
34. Should you be taking tamoxifen? Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691 [No Abstract] [Full Text] [Related]
35. [First drug for prevention of breast cancer]. MMW Fortschr Med; 1999 Aug; 141(34):16. PubMed ID: 10766546 [No Abstract] [Full Text] [Related]
36. Keeping breast cancer at bay. Women at risk are asked to weigh the pros and cons of a prevention pill. Brink S US News World Rep; 1999 May; 126(21):76. PubMed ID: 10387894 [No Abstract] [Full Text] [Related]
37. Tamoxifen for the prevention of breast cancer in high-risk women. Sweeney FW; Newton WP J Fam Pract; 1999 Feb; 48(2):90-1. PubMed ID: 10037532 [No Abstract] [Full Text] [Related]
38. Letrozole in the extended adjuvant treatment of postmenopausal women with history of early-stage breast cancer who have completed 5 years of adjuvant tamoxifen. Mann BS; Johnson JR; Kelly R; Sridhara R; Williams G; Pazdur R Clin Cancer Res; 2005 Aug; 11(16):5671-7. PubMed ID: 16115902 [TBL] [Abstract][Full Text] [Related]
39. Tamoxifen and breast cancer prevention: what should you tell your patients? Goel V CMAJ; 1998 Jun; 158(12):1615-7. PubMed ID: 9645176 [No Abstract] [Full Text] [Related]